In the murine myelomonocytic leukemia WEHI-
The numerous vertebrate homeobox genes (1, 2) appear to encode DNA-binding transcription factors that may have managerial roles not only in embryogenesis (3) but also in subsequent cellular differentiation processes (4) (5) (6) (7) . While exploring the proposition that homeobox genes help to govern hematopoiesis, we noted (4) that the murine myelomonocytic leukemia cell line WEHI-3B (8, 9) , unlike other myeloid lines, expressed the Hox-2.4 gene, a member of the Hox-2 cluster of homeobox genes on chromosome 11 (10) . Studies by Blatt et al. (11) and our work (12) revealed that an intracisternal A particle (IAP) genome, an endogenous retrovirus-like element, had integrated into the 5' noncoding region of Hox-2.4 and induced its expression. Hence, deregulated Hox-2.4 expression might have contributed to development of the WEHI-3B leukemia. Intriguingly, another IAP insertion in WEHI-3B has induced expression of the myeloid growth factor interleukin 3 (IL-3) (13) , but that alteration alone cannot account for leukemic transformation since enforced autocrine IL-3 production provokes a gross overproduction of mature myeloid cells rather than a true leukemia (14, 15) .
By retroviral delivery, we have evaluated the impact of concerted expression of Hox-2.4 and IL-3 in normal hematopoietic cells and report here that the combination is highly leukemogenic. Whereas IL-3 renders myeloid cells autonomous, Hox-2.4 apparently impedes their programed terminal differentiation. Thus homeobox genes can control cellular maturation. Moreover, together with recent evidence implicating a human homeobox gene in a lymphoid leukemia (16, 17) , these findings indicate that somatic mutations affecting homeobox gene expression can be oncogenic.
METHODS
Retroviruses. To make a retrovirus bearing the IL-3 and Hox-2.4 cDNAs, a Hox-2.4 expression cassette was introduced into an MPZenIL-3 retroviral construct (15) . First, an 812-base-pair (bp) Mlu IlAva I fragment of Hox-2.4 cDNA from WEHI-3B that includes 66 bp of 5' and 17 bp of 3' untranslated sequences (12) was fused to the HindIII-Pst I region of pcDL-SR296 (kindly provided by N. Arai [DNAX, Palo Alto, CA]), which includes the SRa enhancer/promoter and a small simian virus 40 intron (18) . The SRa (Hox-2.4) cassette was then introduced into MPZenIL-3 at the Cla I site, generating MPZenIL-3/Hox-2.4 plasmid. To produce helper-free virus, this construct was electroporated into the qi-2 cell line (19) together with pSV2Neo at a ratio of 10:1.
Transfectants were selected after 10-14 days in the antibiotic G418 (400 ,ug/ml) and expanded, and Southern blots were examined for intact provirus. The 4i-2 clones were titered for virus production by their ability to convert cells of the IL-3-dependent line FDC-P1 (20) to factor independence (15, 21) . The best clone rendered 100% of cells factor independent; by parallel assays with a previously titered MPZipNeo producer line, its titer was estimated to be 106 plaque-forming units (pfu)/ml. The MPZenIL-3-producing line M5 has a titer of 2 x 105 pfu/ml (15) .
Infection and Cell Culture. Cells from femurs of 12 DBA/2 mice treated 4 days earlier with 5-fluorouracil (22, 23) were cocultivated in Dulbecco's modified Eagle's medium (DMEM) containing 20% fetal calf serum, 0.05 mM 2-mercaptoethanol, and 1o0 pokeweed mitogen-stimulated spleen-conditioned medium (PWM-SCM) (24) with virus-producing qi-2 cells plated 24 hr previously at 5 x 104 cells per 10-cm dish (15, 21, 23 (15, 21, 23) , was used to construct a retrovirus bearing the IL-3 and Hox-2.4 genes, denoted MPZenIL-3/ Hox-2.4 ( Fig. la) , and its effects were compared with those of similar viruses expressing the IL-3 (MPZenIL-3; ref. 15) (Fig. lb, lane 2) . To introduce the viruses into diverse primitive hematopoietic cells, we infected bone marrow cells from DBA/2 mice previously treated with 5-fluorouracil to enrich for precursors (22) and monitored their ability to generate colonies in agar and to elicit leukemia in syngeneic mice.
In Vitro Growth. The in vitro growth properties of the infected marrow cells suggest that Hox-2.4 expression impedes terminal myeloid differentiation. As expected (14, 15) , soft agar cultures of marrow cells infected with either IL-3-bearing virus developed colonies in the absence of added factor, but their morphology was strikingly different. Like normal uninfected colonies supported by factor, all factorindependent colonies generated by the IL-3 virus were diffuse ( Fig. 2a) due to the migration of terminally differentiated granulocytes and macrophages. In contrast, like WEHI-3B colonies (Fig. 2d) , a high proportion (50-60%) of the autonomous colonies generated by the IL-3/Hox-2.4 virus were large and compact ( variable nuclear indentation (Fig. 2c) , virtually indistinguishable from WEHI-3B cells (Fig. 2e) lb) . Southern blot analysis with HindIII ( Fig. 3a) revealed that most clones contained one to three proviral inserts. Certain clones derived from the same infection had very different proviral insertion patterns (e.g., C10 and C22 in Fig.  3a) , indicating that more than one precursor cell had been transformed by the virus, but other clones appeared to share a common insert and may represent reinfected siblings of a single transformed cell (not shown). Hence further analysis will be required to establish the frequency of transformation. In Vivo Behavior. The IL-3/Hox-2.4 virus provoked an aggressive and distinctive myeloid disease ( (Fig. 4 a, c, and d) and the alveolar walls of the lungs (not shown) as well as increased numbers of mast cells in the marrow and spleen. Only IL-3 plus Hox-2.4, however, provoked an elevated level of immature myeloid cells in the bone marrow. Myeloblasts and myelocytes were notably elevated (Fig. 4 e and h ) and frequently infiltrated the adjacent muscle (not shown), sometimes in association with hind limb paralysis. Immature myeloid cells were also prominent in the spleen, lymph nodes, and periportal areas of the liver. Autonomous myelomonocytic cell lines were readily obtained from the spleen and bone marrow of these mice, whereas mice reconstituted with MPZenIL-3 virus-infected cells yielded only slowly growing mast cell lines, in agreement with previous studies (14, 15) . d and h) . In the quantitative analysis of leukocytes (a and e), "blast" includes promyelocytes and myeloblasts; "myelo" represents myelocytes; "gran/mon" includes "bands", neutrophils, eosinophils, and monocytes; "Iym" refers to lymphocytes; and "ery" refers to erythroid elements.
The proliferative disorder induced by the MPZenIL-3/ Hox-2.4 virus appears to be at least oligoclonal, since HindIII digests of splenic DNA rarely revealed dominant proviral inserts (e.g., S44, S45, and S46 in Fig. 3a) , despite the high concentration of proviral DNA evident in EcoRI digests (Fig.  3b) . Thus in vivo as well as in vitro results suggest that multiple clones were transformed. Viral RNA was evident in the spleens of transplant recipients (e.g., SP 10, lane 7 in Fig.  lb) , although, curiously, the spliced (3.9 kb) transcript was not prominent.
The myeloid disease elicited by the MPZenIL-3/Hox-2.4 virus was aggressively tumorigenic, in marked contrast to the nontransplantable myeloid hyperplasia induced by viruses producing IL-3 alone (refs. 14 and 15 and Table 1 The critical effect of Hox-2.4 appears to be to retard differentiation, as evidenced by the elevated proportion of immature myeloid cells observed in vitro (Fig. 2 b and c) and in hematopoietic organs (Fig. 4 e and h) Although autocrine growth factor production is implicated in a proportion of leukemias, the hallmark of leukemia is an altered differentiation program that allows indefinite persistence and hence inexorable expansion of the affected clone (27) . Since Hox-2.4 appears to augment self-regenerative divisions at the expense of terminal maturation, its action is reminiscent of that of nuclear oncoproteins such as myc or myb (28) (29) (30) (31) , and the collaboration with IL-3 may parallel their synergy with ras. Factor-dependent myeloid cell lines such as FDC-P1, which can be transformed simply by enforced IL-3 expression (15, 32) , presumably harbor a mutation enhancing self-renewal. In some such lines, the Zn finger gene evi-J has been induced (33) , so its action may be akin to that of Hox-2.4. Hox-2.4 might be oncogenic because it mimics the action of a homeobox gene product that normally maintains ability to self-renew or because it inhibits the function of one needed for terminal differentiation. The similar structures and shared DNA recognition sequences of many Antennapedia-like homeobox genes, such as Hox-2.4, favor the view that their gene products can replace or compete with one another (2) .
These results suggest that a new reservoir of oncogenes may be provided by the large vertebrate homeobox gene family. Although Hox-2.4 itself was expressed in only 2 of 31 leukemia cell lines surveyed, many homeobox genes are very similar to it (12) . Moreover, the human Hox-2 locus maps to the long arm of chromosome 17 near breakpoints implicated in hematologic malignancies (34) (35) (36) . Recent findings indicate that the t(1;19) translocation common to human acute lymphoblastic (pre-B) leukemia generates a chimeric polypeptide bearing a very divergent homeodomain (16, 17) . Thus certain homeobox genes may be rendered oncogenic either by deregulated expression, as shown here for Hox-2.4, or by an altered coding region, as inferred for the t(1;19).
